DDIS-26. HIGH-THROUGHPUT DRUG SCREENING OF MENINGIOMAS IDENTIFIES HDAC INHIBITORS AS PROMISING TARGETS ACROSS GRADES

Meningiomas are a common central nervous system (CNS) tumor, accounting for one third of CNS neoplasms. To date, no FDA approved pharmacotherapy exists for meningiomas. In an effort to identify potential treatments for meningiomas we created a culture system that allows us to grow and screen tumors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Tatman, Philip, Fringuello, Anthony, Wroblewski, Teddy, Scherer, Sam, Foreman, William, Ryan Ormond, D, Damek, Denise, Lillehei, Kevin, Jensen, Randy, Graner, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Drug Discovery
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847367/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.277
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados